Nanoparticles loaded with bee venom kill HIV
(Medical Xpress)—Nanoparticles carrying a toxin found in bee venom can destroy human immunodeficiency virus (HIV) while leaving surrounding cells unharmed, researchers at Washington University School of ...
HIV & AIDS
Mar 08, 2013 |
5 / 5 (29) |
3
|
Biologists deliver neutralizing antibodies that protect against HIV infection in mice
Over the past year, researchers at the California Institute of Technology, and around the world, have been studying a group of potent antibodies that have the ability to neutralize HIV in the lab; their hope ...
HIV & AIDS
Nov 30, 2011 |
5 / 5 (3) |
0
|
HPV vaccine may benefit HIV-infected women, study finds
(Medical Xpress)—Women with HIV may benefit from a vaccine for human papillomavirus (HPV), despite having already been exposed to HPV, a study finds. Although many may have been exposed to less serious forms of HPV, more ...
HIV & AIDS
Nov 09, 2012 |
not rated yet |
0
|
Research underscores Truvada's potency in preventing the transmission of HIV
New research from an international team of HIV/AIDS experts has reaffirmed the effectiveness of Truvada—the first and only medication approved by the FDA for HIV prevention. Led by Gladstone Investigator Robert Grant, MD, ...
HIV & AIDS
Sep 12, 2012 |
not rated yet |
0
|
The best strategy to defeat HIV in South Africa—study challenges WHO's approach
The World Health Organization is about to roll out a new strategy for AIDS prevention in South Africa, a country where more than 5 million people are infected with HIV. Based on a mathematical model, the WHO predicts this ...
HIV & AIDS
Sep 05, 2012 |
not rated yet |
0
|
Anti-HIV vaginal ring can prevent virus transmission: animal study
Population Council scientists have found that a vaginal ring releasing an anti-HIV drug can prevent the transmission of SHIV in macaques. This study provides the first efficacy data on the delivery of a microbicide from a ...
HIV & AIDS
Sep 05, 2012 |
5 / 5 (3) |
0
|
Progress against HIV thwarted by patients' unmet needs
In a groundbreaking study published last year, scientists reported that effective treatment with HIV medications not only restores health and prolongs life in many HIV-infected patients, but also curtails transmission to ...
HIV & AIDS
Apr 26, 2012 |
not rated yet |
0
|
Research on cash payments to promote health: Ethical concerns may be misplaced
It is fairly common for clinical research participants to receive payment for expenses such as travel and parking. What has raised ethical questions are payments or incentives given to encourage people to participate in research ...
Health
Mar 27, 2012 |
not rated yet |
0
|
Aspirin merits testing for prevention of cervical cancer in HIV-infected women
Research conducted by NewYork-Presbyterian Hospital/Weill Cornell Medical Center global health investigators and cancer specialists in New York, Qatar and Haiti suggests that aspirin should be evaluated for its ability to ...
Cancer
Jan 18, 2012 |
not rated yet |
0
|
HIV prevention research named scientific breakthrough of the year by Science
The HIV Prevention Trials Network 052 study, led by Myron S. Cohen, MD of the University of North Carolina at Chapel Hill, has been named the 2011 Breakthrough of the Year by the journal Science.
HIV & AIDS
Dec 22, 2011 |
5 / 5 (3) |
3
|
When prophecy fails: How to better predict success in HIV prevention clinical trials
New research from the University of North Carolina at Chapel Hill schools of medicine and pharmacy may help explain the failure of some recent clinical trials of prevention of HIV infection, compared to the ...
HIV & AIDS
Dec 07, 2011 |
not rated yet |
0
|
Researchers suggest unconventional approach to control HIV epidemics
(Medical Xpress) -- A new weapon has emerged to prevent HIV infection. Called pre-exposure prophylaxis, or PrEP, it is a strategy of providing medications to at-risk people before they are exposed to the virus. Having shown ...
HIV & AIDS
Dec 07, 2011 |
5 / 5 (1) |
1
|
HIV trial scrapped after gel found to be ineffective
In a major setback for AIDS prevention research, a clinical trial of a new vaginal gel supposed to reduce HIV infections has been suspended after studies showed it to be ineffective.
HIV & AIDS
Nov 27, 2011 |
not rated yet |
2
Study: Gates project spared 100K Indians from HIV
(AP) -- An estimated 100,000 people in India may have escaped HIV infection over five years thanks to one of the world's biggest prevention programs, an encouraging sign that targeting high-risk groups remains vital even ...
HIV & AIDS
Oct 11, 2011 |
5 / 5 (4) |
0
New HIV infections in US hold steady at 50,000
(AP) -- The number of Americans infected with the AIDS virus each year has been holding steady at about 50,000, according to a government report released Wednesday.
HIV & AIDS
Aug 03, 2011 |
2 / 5 (1) |
0
